The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria.

Cost Eff Resour Alloc

Health Economic Research Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK.

Published: May 2012

Objective: To determine the time spent and income lost by patients and their households for seeking tuberculosis diagnosis and treatment in Bauchi State-Nigeria.

Method: A cross sectional study where 242 TB patients were sampled from 27 out of 67 facilities providing TB services in a north-eastern state of Nigeria. Sampling was stratified based on facility type, patients' HIV status and gender.

Results: The income lost among the hospitalized group was estimated at $156/patient and about $114 in the non-hospitalized patients group. Age, gender, facility of diagnosis, level of education and occupation were significant (p-values <0.05) associated with total (both patients and their households) income lost. However, AFB sputum-smear result and HIV status had no significant effects on the income lost. Hospitalised patients spent an average time of 924.98 hours for diagnosis and treatment whereas the non-hospitalised spent an average of 141.29 hours. The estimated US dollar valued of these hours was US517.98 and US$79.13 for hospitalised and non-hospitalised patient groups respectively. Hospitalisation and the facility of diagnosis were statistically significant (p-value <0.05) predictors of the time patients and household spent on TB.

Conclusion: Tuberculosis poses causes tremendous burden in terms of time and productivity lost to both patients and their households in Bauchi State Nigeria.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439351PMC
http://dx.doi.org/10.1186/1478-7547-10-6DOI Listing

Publication Analysis

Top Keywords

treatment bauchi
8
income lost
8
indirect cost
4
cost pulmonary
4
pulmonary tuberculosis
4
patients
4
tuberculosis patients
4
patients receiving
4
receiving treatment
4
bauchi state-nigeria
4

Similar Publications

Objective: This paper examines the outcomes of the public sector capacity strengthening (PSCS) approach and how they contribute to the promotion of maternal, newborn, and child health, and nutrition (MNCH+N), family planning (FP) and malaria prevention-related outcomes.

Design: The qualitative study implemented from July to August of 2022 used the outcome harvesting methodology and key informant interviews to elicit information including most significant change (MSC) stories to evaluate project outcomes over 5 years (2017-2022).

Setting: The study was conducted in Sokoto, Kebbi, Nasarawa, Bauchi and Ebonyi states of Nigeria.

View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a disease that affects millions of people globally making it a major public health concern. It is defined as an abrupt decrease in kidney function that occurs within ours affecting both the structure and functionality of the kidneys.The outcome of AKI and the determinants in Nigeria are largely unknown.

View Article and Find Full Text PDF

Effect of health education in the control of schistosomiasis in Dass Emirate Council of Bauchi State, Nigeria: An intervention study.

PLoS Negl Trop Dis

January 2025

Disease control and immunization unit, Bauchi State Primary Health Care Development Agency, Dass Emirate, Nigeria.

Objective: Schistosomiasis has been recognized by WHO as a major contributor to mortality and morbidity, particularly in Sub-Sahara Africa, where it is most prevalent. There is a lack of reliable data on the effectiveness of health education interventions in reducing the prevalence of schistosomiasis in Bauchi State. Hence, the study assessed the prevalence of schistosomiasis and the knowledge, attitude and practices of community members of Dass Emirate towards the prevention and control of schistosomiasis before and after health education intervention.

View Article and Find Full Text PDF

Neuropathic pain (NP) is a chronic condition caused by abnormal neuronal excitability in the nervous system. Current treatments for NP are often ineffective or poorly tolerated. Hence, we reviewed the efficacy and safety of novel drugs or devices that target neuronal excitability in NP patients compared with placebo, sham, or usual care interventions.

View Article and Find Full Text PDF

Background: The advancement in non-invasive methods for diagnosing and characterizing liver disease has achieved significant success. One such methods, FibroScan, combines non-invasiveness, rapidity, painlessness, and reproducibility. However, its accuracy and value are limited in many clinical settings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!